Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study

To characterize unmet treatment needs in a sample of Migraine in America Symptoms and Treatment (MAST) Study participants using oral, acute prescription migraine medications.

[1]  Ivy Shiue,et al.  Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.

[2]  R. Lipton,et al.  Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences , 2018, Headache.

[3]  R. Lipton,et al.  The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility , 2018, The Journal of Headache and Pain.

[4]  Sojib Bin Zaman,et al.  Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. , 2017, The Lancet. Neurology.

[5]  Richard B. Lipton,et al.  Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study , 2016, Headache.

[6]  D. Buse,et al.  Acute Treatment Optimization in Episodic and Chronic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study , 2015, Headache.

[7]  R. Lipton,et al.  Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine , 2015, Neurology.

[8]  F. Ponti,et al.  Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies , 2015, Cephalalgia : an international journal of headache.

[9]  S. Silberstein,et al.  The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies , 2015, Headache.

[10]  M. Ferrari,et al.  What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study , 2014, PloS one.

[11]  D. Buse,et al.  Effects of Switching Acute Treatment on Disability in Migraine Patients Using Triptans , 2013, Headache.

[12]  D. Buse,et al.  Examination of Unmet Treatment Needs Among Persons With Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study , 2013, Headache.

[13]  R. Ohrbach,et al.  The International Classification of Headache Disorders, 3rd edition (beta version) , 2013, Cephalalgia : an international journal of headache.

[14]  D. Buse,et al.  Barriers to the Diagnosis and Treatment of Migraine: Effects of Sex, Income, and Headache Features , 2013, Headache.

[15]  J. Fisher,et al.  Emergency department consultations for patients with neurological emergencies , 2011, European journal of neurology.

[16]  S. Landy,et al.  Assessing the Impact of Migraine Onset on Work Productivity , 2011, Journal of occupational and environmental medicine.

[17]  C. Spitzer,et al.  A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. , 2010, Journal of affective disorders.

[18]  R. Lipton,et al.  Validity and Reliability of the Migraine-Treatment Optimization Questionnaire , 2009, Cephalalgia : an international journal of headache.

[19]  Rrio Op-amps.  FEATURES , 2008 .

[20]  R. Lipton,et al.  Cutaneous allodynia in the migraine population , 2008, Annals of neurology.

[21]  R. Lipton,et al.  Migraine prevalence, disease burden, and the need for preventive therapy , 2007, Neurology.

[22]  S. Silberstein,et al.  Acute Migraine Treatment: Patterns of Use and Satisfaction in a Clinical Population , 2006, Headache.

[23]  M. Gulliford,et al.  Headache and migraine in primary care: consultation, prescription, and referral rates in a large population , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  R. Lipton,et al.  An Assessment of the Burden of Migraine using the Willingness to Pay Model , 2005, Cephalalgia : an international journal of headache.

[25]  K. Adams,et al.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.

[26]  R. Lipton,et al.  Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). , 2004, Clinical therapeutics.

[27]  A. Dowson,et al.  Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire , 2004, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

[28]  Jes Olesen,et al.  The International Classification of Headache Disorders: 2nd edition. , 2004, Cephalalgia : an international journal of headache.

[29]  S. Feldman,et al.  Health Care Utilization in Patients With Migraine: Demographics and Patterns of Care in the Ambulatory Setting , 2003, Headache.

[30]  D. Nash,et al.  Reliability and Validity of the Migraine Therapy Assessment Questionnaire , 2002, Headache.

[31]  R. Lipton,et al.  What Do Patients With Migraine Want From Acute Migraine Treatment? , 2002, Headache.

[32]  W F Stewart,et al.  Migraine Diagnosis and Treatment: Results From the American Migraine Study II , 2001, Headache.

[33]  R. Lipton,et al.  Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II , 2001, Headache.

[34]  Lippincott Williams Wilkins,et al.  Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001, Neurology.

[35]  R. Lipton,et al.  Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers , 2000, Pain.

[36]  S. Silberstein.  Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) , 2000, Neurology.

[37]  N. Santanello,et al.  Determinants of Patient Satisfaction With Migraine Therapy , 2000, Cephalalgia : an international journal of headache.

[38]  R. Lipton,et al.  Acute Migraine Therapy: Do Doctors Understand What Patients With Migraine Want From Therapy? , 1999 .

[39]  R. Lipton,et al.  Classification of daily and near-daily headaches , 1996, Neurology.

[40]  A Keys,et al.  Indices of relative weight and obesity. , 1972, Journal of chronic diseases.

[41]  M. Arnold.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.

[42]  K. Blennow,et al.  Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2018, Front. Neurol..

[43]  W F Stewart,et al.  Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. , 1992, JAMA.